Mary A. Katofiasc

809 total citations
16 papers, 547 citations indexed

About

Mary A. Katofiasc is a scholar working on Urology, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, Mary A. Katofiasc has authored 16 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Urology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Social Psychology. Recurrent topics in Mary A. Katofiasc's work include Urinary Bladder and Prostate Research (11 papers), Neuropeptides and Animal Physiology (8 papers) and Neuroendocrine regulation and behavior (4 papers). Mary A. Katofiasc is often cited by papers focused on Urinary Bladder and Prostate Research (11 papers), Neuropeptides and Animal Physiology (8 papers) and Neuroendocrine regulation and behavior (4 papers). Mary A. Katofiasc collaborates with scholars based in United States, Switzerland and Denmark. Mary A. Katofiasc's co-authors include Karl B. Thor, Hansjörg Danuser, Johannes P. Springer, Jeffrey S. Nissen, James E. Audia, Lesley Marson, John M. Schaus, N.M.J. Rupniak, Edward C. Burgard and F. Aura Kullmann and has published in prestigious journals such as Brain Research, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mary A. Katofiasc

14 papers receiving 489 citations

Peers

Countries citing papers authored by Mary A. Katofiasc

Since Specialization

Citations

This map shows the geographic impact of Mary A. Katofiasc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary A. Katofiasc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary A. Katofiasc more than expected).

Fields of papers citing papers by Mary A. Katofiasc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary A. Katofiasc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary A. Katofiasc. The network helps show where Mary A. Katofiasc may publish in the future.

Co-authorship network of co-authors of Mary A. Katofiasc

This figure shows the co-authorship network connecting the top 25 collaborators of Mary A. Katofiasc. A scholar is included among the top collaborators of Mary A. Katofiasc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary A. Katofiasc. Mary A. Katofiasc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Recent Developments in On-Demand Voiding Therapies 2024 ·Journal of Pharmacology and Experimental Therapeutics ·Karl B. Thor, Lesley Marson, Mary A. Katofiasc, Daniel J. Ricca, Edward C. Burgard	1
2	Colorectal and bladder prokinetic activity of [Lys⁵, MeLeu⁹, Nle¹⁰]-NKA_(4–10) after intranasal or sublingual delivery in dogs 2023 ·Canadian Journal of Physiology and Pharmacology ·N.M.J. Rupniak, Mary A. Katofiasc, Jung‐Eun Bae, Karl B. Thor, Lesley Marson	1
3	Chronic, Twice-Daily Dosing of an NK2 Receptor Agonist [Lys ⁵ ,MeLeu ⁹ ,Nle ¹⁰ ]-NKA(4-10), Produces Consistent Drug-Induced Micturition and Defecation in Chronic Spinal Rats 2019 ·Journal of Neurotrauma ·Lesley Marson, Raymond Piatt, Mary A. Katofiasc, (unknown), Karl B. Thor	8
4	Prokinetic effects of the neurokinin NK2 receptor agonist [Lys5,MeLeu9,Nle10]-NKA(4–10) on bladder and colorectal activity in minipigs 2019 ·Neuropeptides ·N.M.J. Rupniak, Mary A. Katofiasc, Lesley Marson, Daniel J. Ricca, Karl B. Thor, Edward C. Burgard	5
5	[Lys5,MeLeu9,Nle10]-NKA(4–10) Elicits NK2 Receptor–Mediated Micturition and Defecation, and NK1 Receptor–Mediated Emesis and Hypotension, in Conscious Dogs 2018 ·Journal of Pharmacology and Experimental Therapeutics ·N.M.J. Rupniak, Mary A. Katofiasc, Alexander Walz, Karl B. Thor, Edward C. Burgard	12
6	Colorectal and cardiovascular effects of [Lys5,MeLeu9,Nle10]-NKA(4-10) in anesthetized macaques 2018 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·N.M.J. Rupniak, Mary A. Katofiasc, Edward C. Burgard, Karl B. Thor	6
7	NK2 and NK1 receptor-mediated effects of NKA and analogs on colon, bladder, and arterial pressure in anesthetized dogs 2017 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·N.M.J. Rupniak, Mary A. Katofiasc, Lesley Marson, Karl B. Thor	11
8	Prokinetic effects of neurokinin-2 receptor agonists on the bladder and rectum of rats with acute spinal cord transection 2017 ·European Journal of Pharmacology ·Lesley Marson, Karl B. Thor, Mary A. Katofiasc, Edward C. Burgard, N.M.J. Rupniak	21
9	Pharmacodynamic evaluation of Lys5, MeLeu9, Nle10-NKA(4–10) prokinetic effects on bladder and colon activity in acute spinal cord transected and spinally intact rats 2016 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·F. Aura Kullmann, Mary A. Katofiasc, Karl B. Thor, Lesley Marson	26
10	A Positive Modulator of KCa2 and KCa3 Channels, 4,5-Dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591), Inhibits Bladder Afferent Firing in Vitro and Bladder Overactivity in Vivo 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Charlotte Hougaard, (unknown), Chi‐Hsien Chien, Angie L. Bookout, Mary A. Katofiasc, Bo Jensen, Frederik Rode, (unknown), Lene Teuber, Karl B. Thor, Dorte Strøbæk, Edward C. Burgard, Lars Christian B. Rønn	30
11	1371: Chronic Real-Time Ambulatory Urodynamics in Cats Using Radio Telemetry for Drug Screening 2006 ·The Journal of Urology ·K Venkateswarlu, Elizabeth A. Stone, (unknown), Mary A. Katofiasc, (unknown), Kenneth J. Olejar, (unknown), Karl B. Thor	1
12	Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats 2002 ·Life Sciences ·Mary A. Katofiasc, Jeffrey S. Nissen, James E. Audia, Karl B. Thor	83
13	The role of 5-HT1A receptors in control of lower urinary tract function in cats 2002 ·Brain Research ·Karl B. Thor, Mary A. Katofiasc, Hansjörg Danuser, Johannes P. Springer, John M. Schaus	73
14	Extrinsic Innervation of the Cat Prostate Gland: A Combined Tracing and Immunohistochemical Study 1997 ·The Journal of Urology ·Hansjörg Danuser, Johannes P. Springer, Mary A. Katofiasc, Karl B. Thor	31
15	Extrinsic Innervation of the Cat Prostate Gland 1997 ·The Journal of Urology ·Hansjörg Danuser, Johannes P. Springer, Mary A. Katofiasc, Karl B. Thor	2
16	Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. 1995 ·Journal of Pharmacology and Experimental Therapeutics ·Karl B. Thor, Mary A. Katofiasc	236

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact